This insider cluster is routine and non-informative. The CEO's option exercises and same-day sales are standard cashless exercise mechanics, not a bearish signal. No action warranted; monitor for any material corporate events that could trigger more substantial insider activity.
HALO drugs
HALO drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 4 $71.60entry
- T+1 · 6mo ago −0.10%α +2.50% · $71.53
- T+5 · 5mo ago −1.22%α +1.34% · $70.73
- T+20 · 4mo ago +10.96%α +12.34% · $79.45
- T+60 · 3mo ago +47.14%α +45.26% · $105.35
Price Chart
How similar events traded
Executive Summary
CEO Helen Torley and a director sold a combined ~$214K in open-market shares on June 1, 2026, at ~$66/share. The CEO also exercised options at $12.07 and sold a portion of the resulting shares in a same-day same-window pattern, which is typical for tax-covering and liquidity rather than a bearish signal. The total open-market sales represent ~0.003% of HALO's $7.9B market cap, trivial and routine.
Key Financial Metrics
Key Facts
- CEO Helen Torley sold 1,610 shares open-market on June 1, 2026, for ~$107K.
- Director Bernadette Connaughton sold 1,625 shares open-market on June 1, 2026, for ~$108K.
- CEO also exercised 70,000 options at $12.07 on June 1-3, 2026, and sold a portion of the resulting shares, a routine cashless exercise pattern.
- Total open-market sales of ~$214K represent ~0.003% of HALO's $7.9B market cap, immaterial.
- No other insiders traded in the window; the cluster is limited to two individuals.
Financial Impact
Total open-market sales of ~$214K, or ~0.003% of market cap.
Risk Factors
- None from this filing, the cluster is too small to be informative.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-HALO-1780531645955 |
Track record
15 reports on HALO
1 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.70% at T+20 after the Oct 15, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 9, 20268d ago PTAB Trial Bearish 6/10 Entry $102.98 Now $96.50 +6.29% settles Nov 17
- Nov 6, 202610d ago Press Release Bullish 6/10 Entry $103.63 to $100.27 Now $96.50 −6.88% ▼ −3.24% −5.84% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $103.63 to $100.27 Now $96.50 −6.88% ▼ −3.24% −5.84% vs SPY
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $124.54 to $131.18 Now $96.50 −22.51% ▲ +5.33% +4.62% vs SPY
- Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $124.83 to $128.50 Now $96.50 −22.69% ▲ +2.94% +3.38% vs SPY
- Oct 15, 20264w ago PTAB Trial Bearish 7/10 Entry $121.84 to $125.63 Now $96.50 +20.80% ▼ −3.11% −3.54% vs SPY
- Oct 15, 20264w ago PTAB Trial Bearish 7/10 Entry $121.84 to $125.63 Now $96.50 +20.80% ▼ −3.11% −3.54% vs SPY
- Sep 18, 20268w ago 8-K Mixed 6/10 Entry $112.45 to $113.90 Now $96.50 −14.18% ▲ +1.29% +0.02% vs SPY
- Sep 17, 20268w ago Insider Cluster Neutral 2/10 Entry $112.45 to $113.90 Now $96.50 −14.18% ▲ +1.29% +0.02% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $106.12 to $106.92 Now $96.50 −9.07% ▲ +0.75% −0.36% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers